Cerebral palsy is a chronic neurological disorder that affects movement, muscle tone, and posture, resulting from non-progressive damage to the developing brain during pregnancy or early childhood. The condition arises from various causes such as prenatal hypoxia, premature birth, infection, intracranial hemorrhage, or genetic metabolic disorders. Individuals with cerebral palsy may experience difficulties in motor coordination, muscle stiffness or weakness, and abnormal body posture. In many cases, these motor impairments are accompanied by challenges in sensation, cognition, communication, and behavior.
For patients and families, cerebral palsy can significantly affect daily life, independence, and emotional well-being, making long-term care and rehabilitation essential. In recent years, stem cell therapy for cerebral palsy has emerged as a promising approach aimed at repairing damaged neural tissues and improving motor and cognitive functions. Both stem cell treatment for children and adults with cerebral palsy have shown encouraging potential in enhancing mobility, muscle control, and overall quality of life. Parents exploring stem cell therapy for a cerebral palsy child often find renewed hope in this innovative, science-driven treatment option that seeks to support recovery and improve functional outcomes.
For families facing the challenges of cerebral palsy, traditional rehabilitation often offers limited improvements in motor function or cognitive development. Stem cell therapy for cerebral palsy provides a breakthrough, science-backed treatment that targets the root cause of brain injury — not just the symptoms.
Through the regenerative power of stem cells, this innovative approach aims to repair damaged neural tissue and restore the brain's natural communication pathways. Neural and mesenchymal stem cells can differentiate into neurons and glial cells, replacing damaged or inactive cells and rebuilding neural connections. This process supports the recovery of both movement and cognitive abilities, offering hope for long-term functional improvement.
In addition, stem cell treatment for cerebral palsy enhances the brain's self-repair environment. By releasing neurotrophic factors such as BDNF and GDNF, stem cells promote neuronal survival, stimulate new axonal growth, and improve cerebral blood flow — all critical to restoring neurological function.
Another key benefit lies in the therapy's ability to regulate inflammation. After brain injury, excessive inflammation can worsen damage. Mesenchymal stem cells help calm this process by reducing harmful cytokines and protecting remaining neurons. Moreover, by promoting angiogenesis through the secretion of VEGF, stem cells improve oxygen and nutrient delivery to the affected areas, supporting overall brain metabolism.
Whether for children in early developmental stages or adults striving to regain independence, stem cell therapy for child and adults with cerebral palsy offer a scientifically grounded, forward-looking solution — helping patients move beyond physical limitations and toward a higher quality of life.
Not all stem cells are the same — and when it comes to repairing delicate neural networks, the type and quality of stem cells matter deeply. In stem cell therapy for cerebral palsy, researchers and clinicians primarily use two scientifically proven types: neural stem cells (NSCs) and mesenchymal stem cells (MSCs).
Neural stem cells have the unique ability to develop into neurons, astrocytes, and oligodendrocytes — the essential building blocks of the brain. These cells can help reconstruct damaged neural circuits and restore the communication between brain and muscle, which is crucial for improving mobility, coordination, and cognitive performance.
Mesenchymal stem cells, on the other hand, are renowned for their versatility and strong immunoregulatory effects. They can release a variety of neurotrophic and growth factors that promote nerve regeneration, reduce inflammation, and enhance blood circulation within the injured area. This makes MSCs a cornerstone in modern stem cell treatment for cerebral palsy — offering both neuroprotection and regeneration.
At SunMoon, we use clinically certified, high-purity mesenchymal stem cells derived from carefully screened, ethically sourced umbilical cord tissue. These stem cells are processed under strict GMP standards to ensure safety, activity, and consistency — delivering optimal therapeutic potential for every patient.
Because at SunMoon, we don't just offer treatment — we offer hope, grounded in science.
SunMoon uses GMP-certified mesenchymal stem cells derived from ethically sourced umbilical cord tissue. Each batch is tested for purity, viability, and safety to ensure consistent therapeutic quality and clinical reliability.
Our expert team has published over 40 SCI-indexed papers and developed 13 advanced surgical techniques. With combined expertise in neurology, regenerative medicine, and rehabilitation, we deliver precise, evidence-based care for every patient.
Centered on stem cell therapy, SunMoon integrates traditional Chinese rehabilitation methods with intelligent medical technologies to enhance neural repair and accelerate functional recovery.
With over 30,000 successful clinical cases worldwide, SunMoon has earned the confidence of patients and families across the globe — delivering real, measurable improvements in motor and cognitive functions.
With over 20 years of clinical practice, SunMoon has built one of the world's most comprehensive treatment records in stem cell therapy for cerebral palsy. Since 2003, our medical team has successfully performed over 10,000 cases, helping patients regain mobility, confidence, and independence.
| Spastic Cerebral Palsy | Ataxic Cerebral Palsy |
| Caused by pyramidal tract injury; characterized by high muscle tone and overactive reflexes. | Originates from cerebellar injury; leads to poor balance and coordination. |
| Dyskinetic Cerebral Palsy | Mixed Cerebral Palsy |
| Due to basal ganglia damage; marked by involuntary movements and abnormal posture. | Involves multiple regions, showing combined symptoms of the above types. |
| Improvement Area | Observed Results |
| Motor Function | 1–2 level increase in GMFCS scale; better gait stability, improved hand coordination |
| Muscle Tone | Reduced spasticity (lower Ashworth score), improved joint mobility, corrected abnormal postures |
| Language & Cognition | Enhanced comprehension and expression; cognitive scores (e.g., Gesell scale) up by 30%–50% |
| Sensory Integration | Improved balance, tactile response, visual-motor coordination, and spatial awareness |
| Daily Independence | Greater ability in self-care (eating, dressing); reduced reliance on assistive devices |
| Seizure Reduction | 60% of epilepsy patients reported >50% fewer seizures and reduced medication dosage |
| Emotional & Behavioral Health | Noticeable decrease in anxiety and hyperactivity; improved social interaction and adaptability |
A Seamless, Professional, and Caring Treatment Journey
Online & multilingual consultation services — understand your condition, treatment options, and expected outcomes before arrival.
Visa guidance, itinerary planning, airport pickup, and hospital admission support — ensuring a smooth and worry-free journey to treatment.
Comprehensive health check, expert consultation, and AI-assisted analysis to design a precise, individualized stem cell therapy plan.
Cutting-edge stem cell transplantation combined with modern rehabilitation and traditional Chinese therapies to maximize recovery outcomes.
Remote follow-up, digital health tracking, and long-term recovery guidance through SunMoon's Personal Health Digital Twin Platform.
At SunMoon, science can restore hope — from consultation to recovery, we're with you every step of the way.
Stem cell therapy aims to repair and regenerate damaged brain tissue, improving neural communication and motor control. By replacing injured cells and releasing neurotrophic factors, it can help reduce muscle stiffness, improve mobility, enhance cognitive function, and support overall quality of life in both children and adults with cerebral palsy.
The main stem cells used are mesenchymal stem cells (MSCs) and neural stem cells (NSCs). At SunMoon, all stem cells are ethically sourced and processed under GMP-certified standards to ensure safety and effectiveness.
The cost varies depending on the treatment method, number of stem cell injections, and rehabilitation requirements. On average, a complete treatment program may range from USD $10,000–$25,000. For a precise quotation, our medical consultants will provide a personalized assessment based on your condition and treatment goals.
Recent advancements combine stem cell therapy with AI-assisted rehabilitation and traditional Chinese medicine techniques to enhance neuroplasticity and accelerate recovery. SunMoon's latest innovation — the Personal Health Digital Twin Platform — allows real-time tracking of patient progress and continuous optimization of rehabilitation plans.
Patients are advised to avoid smoking, alcohol, strenuous exercise, and unprescribed medications for at least several weeks post-treatment. Maintaining a balanced diet, adequate rest, and following your doctor's rehabilitation instructions are crucial for achieving the best outcomes.
Cerebral palsy is a non-progressive neurological disorder, meaning the brain injury does not worsen over time but cannot be completely reversed. However, with stem cell therapy combined with intensive rehabilitation, many patients have achieved significant improvements in muscle control, cognition, and independence — greatly enhancing their quality of life.
Appointment
Online Communication